Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
German Clinical Trials Register |
Last refreshed on:
|
8 April 2024 |
Main ID: |
DRKS00015755 |
Date of registration:
|
06/03/2019 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
DanA
|
Scientific title:
|
DanA - Delirium-intervention in the acute-geriatric Setting. A non-pharmacological team-based Approach.
Measurement for the early prevention, recognition and treatment of sudden confusion of older inpatients. |
Date of first enrolment:
|
01/04/2019 |
Target sample size:
|
407 |
Recruitment status: |
Recruiting |
URL:
|
http://drks.de/search/en/trial/DRKS00015755 |
Study type:
|
interventional |
Study design:
|
Allocation: Non-randomized controlled study; Masking: Open (masking not used); Control: No treatment / Standard of care; Assignment: other; Study design purpose: prevention
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Germany
| | | | | | | |
Contacts
|
Name:
|
Claudia
Eckstein |
Address:
|
Theodor-Kutzer-Ufer 1-3
68167
Mannheim
Germany |
Telephone:
|
+49 (0)621 383 2553 |
Email:
|
claudia.eckstein@umm.de |
Affiliation:
|
Universitätsmedizin Mannheim, II Medizinische Universitätsklinik, Sektion Altersmedizin, |
|
Name:
|
Heinrich
Burkhardt-Studienleitung |
Address:
|
Theodor-Kutzer-Ufer 1-3
68167
Mannheim
Germany |
Telephone:
|
+49 (0)621 383 5981 |
Email:
|
heinrich.burkhardt@umm.de |
Affiliation:
|
Universitätsmedizin Mannheim, II. Medizinische Universitätsklinik, Sektion Altersmedizin |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients aged 65 and over (with and without cognitive impairments/dementia); patients with and without delirium at admission, non-ethyltoxic genesis; acute geriatric treatment.
Exclusion criteria: Patients with severely impaired communication skills; estimated hospital stay less than 48 hours.
Age minimum:
65 Years
Age maximum:
105 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
F05.0 F05.1
|
F05.1
|
Delirium not superimposed on dementia, so described
|
Delirium superimposed on dementia
|
F05.0
|
Intervention(s)
|
Group 1: Pre-intervention group (control group) = measurement of prevalence and incidence of delirium (without Intervention) Group 2: Intervention group = Measurement of the effect of a systematic, daily, interprofessional exchange on the prevalence and incidence of delirium. Within the framework of this exchange, any changes and signs that may indicate a delirium are discussed and the consequences of action derived from them for the individual case are coordinated on an interprofessional basis.
|
Primary Outcome(s)
|
Aim: Further development of interprofessional teamwork. T0= before the intervention phase (03(2019); T1= after the intervention phase 11/2019 using the Assessment of Interprofessional Team Collaboration Scale (AITCS-II).
|
Secondary Outcome(s)
|
Collection of primary endpoints of delirium-incidence and prevalence by secondary analysis of routine clinical data of each included patient treated in acute-geriatric ward in the pre-intervention phase (01.10.2018-28.02.2019) and in the intervention phase (01.06.2019-31.10.2019).
|
Source(s) of Monetary Support
|
Netzwerk Alternsforschung (NAR) der Universität Heidelberg
|
UMM MannheimMedizinische Klinik IISektion Altersmedizin/Geriatrisches Zentrum
|
Ethics review
|
Status: Approved
Approval date: 12/12/2018
Contact:
|
|